Fig. 3.

a Body weight. a The highest body weight index (BWI) observed in glucose-containing control group, while the lowest BWI was seen in the metformin group. The BWI was significantly higher in the control group receiving glucose-containing treatment than other groups (p < 0.05). b Blood glucose measurement. The highest level of blood glucose at the beginning and the end of experiment found in the glucose-containing control group, which was significantly higher compared to other groups. At the end of the experiment (after 20 days), the lowest level of blood glucose was seen in the glucose induced group treated with metformin, silymarin, and metformin plus silymarin groups (p < 0.05)